# QT Vascular sells coronary assets to Teleflex for $98.4M

QT Vascular agreed to sell its intellectual property rights for non-drug coated coronary products and an option for a coated product to Teleflex for $98.4 million in cash, plus royalties and supply agreements.

- Type: Acquisition
- Announced: 2018-05-24
- Where: Singapore
- Value: $98.4M
- Status: announced
- Products: non-drug coated coronary products (Chocolate XD, Glider), drug coated coronary balloon catheter (Chocolate Heart)
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Teleflex](https://endata.com/companies/20113.md) (acquirer)
- [Qt Vascular Ltd](https://endata.com/companies/21934.md) (target)
- [Teleflex Life Sciences Unlimited Company](https://endata.com/companies/32054.md) (acquirer)

## Sources

- [straitstimes.com](https://www.straitstimes.com/business/companies-markets/qt-vascular-to-sell-coronary-assets-to-telefex), 2018-05-24: "The proposed sale represents an 'attractive opportunity' for the group to realise the value of its products"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.